Hand-Foot-and-Mouth Disease

Hand-Foot-and-Mouth Disease

Clinically reviewed Aug 29, 2026 Updated Aug 30, 2026
Printable version

Clinical Snapshot

Hand-foot-and-mouth disease is a common viral illness caused by an enterovirus — most often coxsackievirus A16, with enterovirus A71 and, increasingly, coxsackievirus A6 also well documented as causes.[1][2] It mostly affects young children, though it can occur at any age, and outbreaks are most common in the summer and fall in Canadian surveillance experience (international data describes a late-spring/early-summer peak).[3][1] The illness is highly contagious: it spreads through contact with an infected person's saliva or stool, with the virus getting onto hands or shared objects and then into someone else's mouth, and also through respiratory droplets and direct contact with fluid from a ruptured skin lesion.[3][1] A person is most contagious during the first week of illness, but the virus continues to be shed in stool for several weeks after symptoms resolve — one Canadian source specifies up to about 4 weeks — which is why hand hygiene remains important well after a child looks and feels better.[3][2]

The classic pattern is painful mouth ulcers together with a rash of red spots, often with small blisters on top, on the palms and soles and sometimes the buttocks, groin, knees, or elbows — typically preceded by a day or two of fever, poor appetite, and general malaise.[3][2] HFMD is generally a mild, self-limited illness that resolves on its own within about 7-10 days, and there is no licensed antiviral treatment — management is entirely supportive.[3][2][1] The single most important practical issue for a pharmacist to anticipate is hydration: painful oral ulcers can meaningfully reduce a young child's willingness to eat or drink, and dehydration — not the rash, and not the virus itself — is the most common reason a child with HFMD ends up needing medical care.[2] A smaller, genuinely important secondary role is correcting two common counselling gaps: that aspirin should never be used for a child's fever given Reye syndrome risk, and that OTC topical oral anesthetics carry specific pediatric age cautions that make them a poor first reach for a young child's mouth pain.

Professional reference only. Apply clinical judgment and verify patient-specific decisions against current authoritative guidance and product information.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.